Healthcare innovation is one of the EU's most consistently funded priorities, and for good reason. Europe faces an aging population, rising rates of chronic disease, and persistent gaps in diagnostic access across member states. The response from the EU's Horizon Europe and related programmes is a steady stream of open calls targeting exactly these challenges.
If you're building in healthcare, diagnostics, or life sciences, there's a strong chance your work aligns with at least one currently open grant programme. Below are four worth knowing about right now.
1. Advancing Bio-printing of Living Cells for Regenerative Medicine
Up to €12M | Deadline: 22 September 2027
This call targets next-generation bio-printing technologies, specifically the development of systems that can print living cells for use in regenerative medicine applications. Think tissue engineering, organ repair, and personalised medical solutions that move beyond current scaffold-based approaches.
Who it's for: research consortia, university spin-outs, and SMEs developing bio-fabrication platforms, bioinks, or clinical validation pipelines for printed tissue applications.
2. Portable and Versatile Point-of-Care Diagnostics
Up to €10M | Deadline: 13 April 2027 (Stage 1)
Diagnostic access remains highly unequal across Europe, and the EU is funding solutions. This call supports the development of portable, affordable diagnostic technologies that can be deployed outside traditional hospital settings: in pharmacies, GP practices, remote communities, and resource-limited environments.
Who it's for: MedTech startups and SMEs building hardware-software diagnostic systems, rapid testing platforms, or connectivity solutions for decentralised care.
3. Innovative Healthcare Interventions for Non-Communicable Diseases
Up to €10M | Deadline: 13 April 2027 (Stage 1)
Chronic and non-communicable diseases (cardiovascular disease, diabetes, cancer, mental health conditions) account for the majority of Europe's healthcare burden. This call funds innovative intervention models, not just research: prevention programmes, digital therapeutics, behavioural tools, and integrated care approaches that demonstrate measurable outcomes.
Who it's for: companies and consortia working at the intersection of digital health, preventive medicine, and patient-centred care design.
4. Living Labs to Monitor and Mitigate Carcinogenic Substances
Up to €12M | Deadline: 21 September 2027
This call focuses on environmental health, specifically the development of living lab infrastructures that can evaluate carcinogenic risks from environmental exposure and measure their effect on human health outcomes. It sits at the crossroads of public health policy, environmental monitoring, and preventive oncology.
Who it's for: research organisations, public health agencies, and companies developing environmental sensing, biomonitoring, or data integration technologies.
What These Calls Have in Common
These aren't grants for early-stage R&D in isolation. EU health calls at this scale typically expect applicants to demonstrate a credible path to clinical or market deployment, meaningful partnerships across at least two or three EU member states, and a clear connection to Horizon Europe's mission of improving health outcomes across the continent.
That means the strongest applications will combine scientific rigour with a well-articulated commercialisation or implementation strategy, not one or the other.
Browse All Open Healthcare Grants
These are just four of the open calls currently listed across EU and national programmes. If you're building in health, diagnostics, or life sciences, there are more to explore.
Browse all open grants on grantia.se/grants →
Not sure which programme fits your stage or technology? Get in touch, we help companies identify the right calls and develop applications that meet the programme's expectations.